440 related articles for article (PubMed ID: 32605658)
61. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
62. Overaccumulation of p53-mediated autophagy protects against betulinic acid-induced apoptotic cell death in colorectal cancer cells.
Wang S; Wang K; Zhang C; Zhang W; Xu Q; Wang Y; Zhang Y; Li Y; Zhang Y; Zhu H; Song F; Lei Y; Bu Y
Cell Death Dis; 2017 Oct; 8(10):e3087. PubMed ID: 28981110
[TBL] [Abstract][Full Text] [Related]
63. Gambogic acid counteracts mutant p53 stability by inducing autophagy.
Foggetti G; Ottaggio L; Russo D; Monti P; Degan P; Fronza G; Menichini P
Biochim Biophys Acta Mol Cell Res; 2017 Feb; 1864(2):382-392. PubMed ID: 27899303
[TBL] [Abstract][Full Text] [Related]
64. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.
Shin JW; Chun KS; Kim DH; Kim SJ; Kim SH; Cho NC; Na HK; Surh YJ
Biochem Pharmacol; 2020 Mar; 173():113820. PubMed ID: 31972171
[TBL] [Abstract][Full Text] [Related]
65. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.
Smolková K; Mikó E; Kovács T; Leguina-Ruzzi A; Sipos A; Bai P
Antioxid Redox Signal; 2020 Nov; 33(13):966-997. PubMed ID: 31989830
[No Abstract] [Full Text] [Related]
66. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
[TBL] [Abstract][Full Text] [Related]
67. NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
Chen D; Tavana O; Chu B; Erber L; Chen Y; Baer R; Gu W
Mol Cell; 2017 Oct; 68(1):224-232.e4. PubMed ID: 28985506
[TBL] [Abstract][Full Text] [Related]
68. Gentian violet induces wtp53 transactivation in cancer cells.
Garufi A; D'Orazi V; Arbiser JL; D'Orazi G
Int J Oncol; 2014 Apr; 44(4):1084-90. PubMed ID: 24535435
[TBL] [Abstract][Full Text] [Related]
69. Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
Tu ZS; Wang Q; Sun DD; Dai F; Zhou B
Eur J Med Chem; 2017 Jul; 134():72-85. PubMed ID: 28399452
[TBL] [Abstract][Full Text] [Related]
70. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage.
Kang ES; Woo IS; Kim HJ; Eun SY; Paek KS; Kim HJ; Chang KC; Lee JH; Lee HT; Kim JH; Nishinaka T; Yabe-Nishimura C; Seo HG
Free Radic Biol Med; 2007 Aug; 43(4):535-45. PubMed ID: 17640564
[TBL] [Abstract][Full Text] [Related]
71. Glyceollins Modulate Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer in a
Jeong G; Oh J; Kim JS
J Med Food; 2019 May; 22(5):521-528. PubMed ID: 30924710
[TBL] [Abstract][Full Text] [Related]
72. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
73. Does Nrf2 contribute to p53-mediated control of cell survival and death?
Chen W; Jiang T; Wang H; Tao S; Lau A; Fang D; Zhang DD
Antioxid Redox Signal; 2012 Dec; 17(12):1670-5. PubMed ID: 22559194
[TBL] [Abstract][Full Text] [Related]
74. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
Kang JS; Nam LB; Yoo OK; Keum YS
Biochem Pharmacol; 2020 Jul; 177():114002. PubMed ID: 32360363
[TBL] [Abstract][Full Text] [Related]
75. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
76.
Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
[TBL] [Abstract][Full Text] [Related]
77. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.
Puca R; Nardinocchi L; Porru M; Simon AJ; Rechavi G; Leonetti C; Givol D; D'Orazi G
Cell Cycle; 2011 May; 10(10):1679-89. PubMed ID: 21508668
[TBL] [Abstract][Full Text] [Related]
78. NRF2 and p53: Januses in cancer?
Rotblat B; Melino G; Knight RA
Oncotarget; 2012 Nov; 3(11):1272-83. PubMed ID: 23174755
[TBL] [Abstract][Full Text] [Related]
79. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
Yang C; Zhang X; Fan H; Liu Y
Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907
[TBL] [Abstract][Full Text] [Related]
80. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]